During the past decade, Pacific Cancer Institute of Maui conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 42 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Cancer Institute of Maui" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NSABP Foundation Inc" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Cancer Institute of Maui" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Cancer Institute of Maui" are "Breast Cancer" (10 trials), "Prostate Cancer" (5 trials), "Chemotherapeutic Agent Toxicity" (4 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (3 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Pacific Cancer Institute of Maui" in a lesser frequency.

Most popular intervention types in "Pacific Cancer Institute of Maui" are "Drug" (45 trials), "Other" (31 trials), "Biological" (24 trials), "Procedure" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Bevacizumab" (15 trials), "Paclitaxel" (11 trials), "Carboplatin" (9 trials) and "Quality-of-Life Assessment" (9 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Cancer Institute of Maui" are 31 trials for "All" genders, 16 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Pacific Cancer Institute of Maui". undefined are not yet recruiting, 1 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Pacific Cancer Institute of Maui, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Cancer Institute of Maui, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".